![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
![[IMG]](/icons/image2.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| Advisory_Extension_for_the_Call_for_HTAC_Nominations_-_January_2023.pdf | 2024-02-28 11:15 | 119K | |
| HTA-Weekly-Evidence-Report-03-to-09-December-2022.pdf | 2024-02-27 16:37 | 467K | |
| HTA-Weekly-Evidence-Report-10-to-17-December-2022.pdf | 2024-02-27 16:34 | 529K | |
| HTA-Weekly-Evidence-Report-17-to-23-December-2022.pdf | 2024-02-27 16:25 | 501K | |
| HTA-Weekly-Evidence-Report-26-November-to-02-December-2022.pdf | 2024-02-27 16:40 | 547K | |
| PSCP-1-150x150.png | 2024-02-13 15:59 | 46K | |
| PSCP-1-300x225.png | 2024-02-13 15:59 | 128K | |
| PSCP-1-500x375.png | 2024-02-13 15:59 | 330K | |
| PSCP-1-768x576.png | 2024-02-13 15:59 | 704K | |
| PSCP-1-1024x768.png | 2024-02-13 15:59 | 1.1M | |
| PSCP-1.png | 2024-02-13 15:59 | 3.7M | |
| Signed-Advisory_-HTA-Philippine-Social-Values-Guide-2022.pdf | 2024-02-28 11:24 | 694K | |
| dc2022-0625_inclusion_of_abiraterone_and_non_inclusion_of_enzalutamide.pdf | 2024-02-28 11:17 | 141K | |
| dm2022-0545.pdf | 2024-02-28 11:22 | 4.1M | |